Cyclodextrins in delivery systems : Applications
Cyclodextrins (CDs) are a family of cyclic oligosaccharides with a hydrophilic outer surface and a lipophilic central cavity. CD molecules are relatively large with a number of hydrogen donors and acceptors and, thus in general, they do not permeate lipophilic membranes. In the pharmaceutical industry, CDs have mainly been used as complexing agents to increase aqueous solubility of poorly soluble drugs and to increase their bioavailability and stability. CDs are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current CD-based therapeutics is described and possible future applications are discussed. CD-containing polymers are reviewed and their use in drug delivery is presented. Of specific interest is the use of CD-containing polymers to provide unique capabilities for the delivery of nucleic acids. Studies in both humans and animals have shown that CDs can be used to improve drug delivery from almost any type of drug formulation. Currently, there are approximately 30 different pharmaceutical products worldwide containing drug/CD complexes in the market.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Journal of pharmacy & bioallied sciences - 2(2010), 2 vom: 03. Apr., Seite 72-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tiwari, Gaurav [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Colon |
|---|
| Anmerkungen: |
Date Completed 10.11.2011 Date Revised 20.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/0975-7406.67003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM210489634 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM210489634 | ||
| 003 | DE-627 | ||
| 005 | 20240320232217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/0975-7406.67003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM210489634 | ||
| 035 | |a (NLM)21814436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tiwari, Gaurav |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cyclodextrins in delivery systems |b Applications |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.11.2011 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Cyclodextrins (CDs) are a family of cyclic oligosaccharides with a hydrophilic outer surface and a lipophilic central cavity. CD molecules are relatively large with a number of hydrogen donors and acceptors and, thus in general, they do not permeate lipophilic membranes. In the pharmaceutical industry, CDs have mainly been used as complexing agents to increase aqueous solubility of poorly soluble drugs and to increase their bioavailability and stability. CDs are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current CD-based therapeutics is described and possible future applications are discussed. CD-containing polymers are reviewed and their use in drug delivery is presented. Of specific interest is the use of CD-containing polymers to provide unique capabilities for the delivery of nucleic acids. Studies in both humans and animals have shown that CDs can be used to improve drug delivery from almost any type of drug formulation. Currently, there are approximately 30 different pharmaceutical products worldwide containing drug/CD complexes in the market | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Complexation | |
| 650 | 4 | |a colon | |
| 650 | 4 | |a rectal | |
| 650 | 4 | |a targeted drug delivery | |
| 650 | 4 | |a transdermal | |
| 700 | 1 | |a Tiwari, Ruchi |e verfasserin |4 aut | |
| 700 | 1 | |a Rai, Awani K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pharmacy & bioallied sciences |d 2010 |g 2(2010), 2 vom: 03. Apr., Seite 72-9 |w (DE-627)NLM20456185X |x 0975-7406 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2010 |g number:2 |g day:03 |g month:04 |g pages:72-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/0975-7406.67003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2010 |e 2 |b 03 |c 04 |h 72-9 | ||